These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19679881)

  • 1. The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies.
    Tchakarska G; Le Lan-Leguen A; Roth L; Sola B
    Haematologica; 2009 Dec; 94(12):1781-2. PubMed ID: 19679881
    [No Abstract]   [Full Text] [Related]  

  • 2. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
    Tiemann K; Alluin JV; Honegger A; Chomchan P; Gaur S; Yun Y; Forman SJ; Rossi JJ; Chen RW
    Leuk Lymphoma; 2011 Nov; 52(11):2148-54. PubMed ID: 21745168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1-negative mantle cell lymphoma.
    Seto M
    Blood; 2013 Feb; 121(8):1249-50. PubMed ID: 23429984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
    Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
    Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
    Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
    Suzuki R; Takemura K; Tsutsumi M; Nakamura S; Hamajima N; Seto M
    Am J Pathol; 2001 Aug; 159(2):425-9. PubMed ID: 11485900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
    Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
    Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
    Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
    Masamha CP; Albrecht TR; Wagner EJ
    J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation.
    Kondo T; Iguchi M; Yoshida S; Yoshino T; Kojima K
    Ann Hematol; 2023 Sep; 102(9):2639-2640. PubMed ID: 37351683
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
    Wickham CL; Armitage H; Joyner MV; Sarsfield P; Boyce M; Wilkins BS; Jones DB; Ellard S
    Med Oncol; 2003; 20(1):77-85. PubMed ID: 12665688
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.
    Herens C; Lambert F; Quintanilla-Martinez L; Bisig B; Deusings C; de Leval L
    Blood; 2008 Feb; 111(3):1745-6. PubMed ID: 18223179
    [No Abstract]   [Full Text] [Related]  

  • 16. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
    Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
    Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma.
    Weinstein S; Emmanuel R; Jacobi AM; Abraham A; Behlke MA; Sprague AG; Novobrantseva TI; Nagler A; Peer D
    PLoS One; 2012; 7(8):e43343. PubMed ID: 22905260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cyclin d1 expression by quantitative real-time, reverse-transcriptase polymerase chain reaction.
    Bijwaard KE; Lichy JH
    Methods Mol Med; 2004; 97():277-95. PubMed ID: 15064500
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
    de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
    Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.